Sponsor or institution

Clinical trials and research at Intra-Cellular Therapies, Inc.

• 11Clinical trials
• 15Countries

Newest trials

All recruiting trials (11)

• Adjunctive JNJ-99245354 for Generalized Anxiety Disorder (GAD)

  This study tests whether adding JNJ-99245354 to existing GAD treatment helps reduce anxiety more than a placebo for adults with GAD who didn’t get adequate benefit from previous treatments.

  Recruiting at 4 sites Phase 3 Intra-Cellular Therapies, Inc. · Temecula, California and 3 other locations · NCT07856420

• Testing ITI-1284 for Generalized Anxiety Disorder (GAD)

  This phase 3 trial tests whether ITI-1284 is safe and tolerable when taken alone or with other medicines by adults with generalized anxiety disorder who haven’t responded to prior treatment.

  Recruiting at 3 sites Phase 3 Intra-Cellular Therapies, Inc. · Los Angeles, California and 2 other locations · NCT07807865

• Treatment of irritability in children with Autism Spectrum Disorder using Lumateperone

  This study is testing if a medication called Lumateperone can help reduce irritability in children with Autism Spectrum Disorder aged 5 to 17.

  Recruiting at 28 sites Phase 3 Intra-Cellular Therapies, Inc. · Little Rock, Arkansas and 40 other locations · NCT06706674

• Treatment for Generalized Anxiety Disorder with ITI-1284

  This study is testing whether a new medication called ITI-1284 can help people with Generalized Anxiety Disorder who haven't found relief from other treatments.

  Recruiting at 49 sites Phase 2 Intra-Cellular Therapies, Inc. · Birmingham, Alabama and 50 other locations · NCT06701903

• Treatment of irritability in children with autism using lumateperone

  This study is testing if a medication called lumateperone can help reduce irritability in children with autism, ages 5 to 17.

  Recruiting at 32 sites Phase 3 Intra-Cellular Therapies, Inc. · Dothan, Alabama and 38 other locations · NCT06690398

• Evaluating ITI-1284 for treating agitation in Alzheimer's patients

  This study tests whether a new medication called ITI-1284 can help reduce agitation in people with Alzheimer's disease.

  Recruiting at 59 sites Phase 2 Intra-Cellular Therapies, Inc. · Anaheim, California and 70 other locations · NCT06651567

• Evaluating ITI-1284 for treating psychosis in Alzheimer's patients

  This study is testing a new medication called ITI-1284 to see if it can help reduce psychotic symptoms in people with Alzheimer's disease.

  Recruiting at 48 sites Phase 2 Intra-Cellular Therapies, Inc. · Anaheim, California and 70 other locations · NCT06540833

• Evaluating ITI-1284 for treating Generalized Anxiety Disorder

  This study is testing a new medication called ITI-1284 to see if it can help people with Generalized Anxiety Disorder who haven't found relief from their current treatments.

  Recruiting at 59 sites Phase 2 Intra-Cellular Therapies, Inc. · Glendale, California and 58 other locations · NCT06480383

• Treatment of Bipolar Depression in Children with Lumateperone

  This study is testing if a new medication called lumateperone can help children and teens aged 10 to 17 who are struggling with depression related to bipolar disorder feel better.

  Recruiting at 37 sites Phase 3 Intra-Cellular Therapies, Inc. · Dothan, Alabama and 67 other locations · NCT06372964

• Assessing the safety of lumateperone in young patients with schizophrenia or bipolar disorder

  This study is testing if lumateperone is safe for young people with schizophrenia or bipolar disorder who will take the medication daily for 26 weeks.

  Recruiting at 52 sites Phase 3 Intra-Cellular Therapies, Inc. · Phoenix, Arizona and 64 other locations · NCT06229210

• Using Lumateperone to help treat major depressive disorder

  This study is testing if adding a medication called lumateperone can help people with major depressive disorder who aren't getting better with their current antidepressants.

  Recruiting at 53 sites Phase 3 Intra-Cellular Therapies, Inc. · Huntsville, Alabama and 68 other locations · NCT05850689

Quick answers

How many clinical trials run by Intra-Cellular Therapies, Inc. are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 15 countries. The most sites are in United States (11 trials), Serbia (8 trials), Bulgaria (5 trials), Czechia (3 trials), Slovakia (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 7, Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →